Switch theme
Sign up to access all valuation multiples
Nihon Kohden Corp manufactures electronic medical equipment. The firm operates in four categories: physiological measuring equipment, treatment equipment, patient monitors, and other medical equipment. The patient monitors segment contributes the largest proportion of revenue and includes continuous monitoring instruments and clinical information systems. The physiological measuring equipment segment sells electroencephalographs, electrocardiographs, and diagnostic information systems. The treatment equipment segment sells defibrillators, pacemakers, ventilators, and related consumables. The other medical equipment segment sells automated hematology analyzers, ultrasound diagnostic equipment, and other laboratory equipment. Nihon Kohden generates the majority of its revenue in Japan.
1951
5.8K+
LTM Revenue $1.6B
LTM EBITDA $174M
$1.8B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Nihon Kohden has a last 12-month revenue (LTM) of $1.6B and a last 12-month EBITDA of $174M.
In the most recent fiscal year, Nihon Kohden achieved revenue of $1.5B and an EBITDA of $228M.
Nihon Kohden expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Nihon Kohden valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.6B | XXX | $1.5B | XXX | XXX | XXX |
| Gross Profit | $809M | XXX | $764M | XXX | XXX | XXX |
| Gross Margin | 52% | XXX | 50% | XXX | XXX | XXX |
| EBITDA | $174M | XXX | $228M | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 15% | XXX | XXX | XXX |
| EBIT | $144M | XXX | $134M | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $98.2M | XXX | $117M | XXX | XXX | XXX |
| Net Margin | 6% | XXX | 8% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Nihon Kohden's stock price is JPY 1719 (or $12).
Nihon Kohden has current market cap of JPY 280B (or $1.9B), and EV of JPY 263B (or $1.8B).
See Nihon Kohden trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.8B | $1.9B | XXX | XXX | XXX | XXX | $0.59 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Nihon Kohden has market cap of $1.9B and EV of $1.8B.
Nihon Kohden's trades at 1.2x EV/Revenue multiple, and 8.2x EV/EBITDA.
Equity research analysts estimate Nihon Kohden's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Nihon Kohden has a P/E ratio of 19.6x.
See valuation multiples for Nihon Kohden and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.9B | XXX | $1.9B | XXX | XXX | XXX |
| EV (current) | $1.8B | XXX | $1.8B | XXX | XXX | XXX |
| EV/Revenue | 1.2x | XXX | 1.2x | XXX | XXX | XXX |
| EV/EBITDA | 10.4x | XXX | 8.2x | XXX | XXX | XXX |
| EV/EBIT | 12.5x | XXX | 13.2x | XXX | XXX | XXX |
| EV/Gross Profit | 2.2x | XXX | n/a | XXX | XXX | XXX |
| P/E | 19.6x | XXX | 16.4x | XXX | XXX | XXX |
| EV/FCF | -159.2x | XXX | 48.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialNihon Kohden's last 12 month revenue growth is 5%
Nihon Kohden's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Nihon Kohden's rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Nihon Kohden's rule of X is 23% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Nihon Kohden and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Growth | 11% | XXX | -2% | XXX | XXX | XXX |
| Rule of 40 | 19% | XXX | 19% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 23% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 41% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nihon Kohden acquired XXX companies to date.
Last acquisition by Nihon Kohden was XXXXXXXX, XXXXX XXXXX XXXXXX . Nihon Kohden acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Nihon Kohden founded? | Nihon Kohden was founded in 1951. |
| Where is Nihon Kohden headquartered? | Nihon Kohden is headquartered in Japan. |
| How many employees does Nihon Kohden have? | As of today, Nihon Kohden has 5.8K+ employees. |
| Who is the CEO of Nihon Kohden? | Nihon Kohden's CEO is Mr. Hirokazu Ogino. |
| Is Nihon Kohden publicy listed? | Yes, Nihon Kohden is a public company listed on TKS. |
| What is the stock symbol of Nihon Kohden? | Nihon Kohden trades under 6849 ticker. |
| When did Nihon Kohden go public? | Nihon Kohden went public in 1961. |
| Who are competitors of Nihon Kohden? | Similar companies to Nihon Kohden include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Nihon Kohden? | Nihon Kohden's current market cap is $1.9B |
| What is the current revenue of Nihon Kohden? | Nihon Kohden's last 12 months revenue is $1.6B. |
| What is the current revenue growth of Nihon Kohden? | Nihon Kohden revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Nihon Kohden? | Current revenue multiple of Nihon Kohden is 1.2x. |
| Is Nihon Kohden profitable? | Yes, Nihon Kohden is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Nihon Kohden? | Nihon Kohden's last 12 months EBITDA is $174M. |
| What is Nihon Kohden's EBITDA margin? | Nihon Kohden's last 12 months EBITDA margin is 11%. |
| What is the current EV/EBITDA multiple of Nihon Kohden? | Current EBITDA multiple of Nihon Kohden is 10.4x. |
| What is the current FCF of Nihon Kohden? | Nihon Kohden's last 12 months FCF is -$11.3M. |
| What is Nihon Kohden's FCF margin? | Nihon Kohden's last 12 months FCF margin is -1%. |
| What is the current EV/FCF multiple of Nihon Kohden? | Current FCF multiple of Nihon Kohden is -159.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
